2018 Pharmacotherapy Update: Volume 4
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Planning CommitteeEric W. Alexander, PharmD, BCPS is a Clinical Consultant for Lumeris
Aman Kaur Chawla, MD is a Senior Clinical Writer for Lumeris
Thomas D. Doerr, MD is the Chairman, Clinical Strategy Committee, Board of Directors for Essence Group Holdings Corporation
Cheryl Earls, RN, BSN, PAHM is a Senior Clinical Consultant for Lumeris
Sara F. Hicks, MSN, FNP-BC is a Senior Clinical Consultant for Lumeris
Lesley Ann Watson, BS, RPH is a Clinical Informatics Analyst for Lumeris
Dani Willett, RN is a Clinical Consultant for Lumeris The committee members have nothing to disclose.
S. Troy McMullin, PharmD is the Director of Clinical Informatics for Lumeris
The committee member holds stock equity in Johnson & Johnson, TEVA.
Allyson R. Zazulia, MD is a Professor of Neurology and the Associate Dean for Continuing Medical Education, Washington University School of Medicine. Dr. Zazulia has no financial relationships to disclose.
Committee members should indicate if speaking off label. Staff of the CME department have oversight of on line modules. All members of the CME department have nothing to disclose.
AuthorsAman Kaur Chawla, MD is a Senior Clinical Writer for Lumeris
Eric W. Alexander, PharmD, BCPS is a Clinical Consultant for Lumeris
- Describe recently published medical findings related to primary care pharmacotherapy.
- Apply these findings to provide safe, efficacious, and cost-effective care to patients.
Target Audience: This course is designed for Internists and Family Medicine physicians, registered nurses, nurse practitioners and physician assistants.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
In support of improving patient care, this activity has been planned and implemented by Lumeris and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hour.
American Academy of Family Physicians (AAFP Credit)
This enduring material activity, Lumeris Clinical Education Course, has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP certification begins June 21, 2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
LUMERIS's mission is to lead the positive evolution of healthcare by providing doctors with the tools, information, and financial incentives they need to practice quality medicine, thereby providing our members access to high-quality service and affordable medical care. The LUMERIS clinical decision support team is made up of physicians, clinical pharmacists, nurse practitioners, and information technology experts. LUMERIS accepts no grants, advertising or donations from the pharmaceutical industry or medical device manufacturers.
- https://www.cdc.gov/mmwr/volumes/67/rr/rr6703a1.htm?s_cid=rr6703a1_w. Accessed: August 29, 2018
- Rosenfeld RM. Otolaryngol Head Neck Surg. 2015;152[S2]:S1-S39
- https://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm. Accessed: October 10, 2018).
- Wolf AM. CA Cancer J Clin. 2018;68:250-281
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.